newsfilter
← Earnings
Earnings Releases·

Envista Holdings Corporation — Third Quarter 2026 Earnings Summary

  • **Financial Results:** Q3 sales reached $691 million (3.2% YoY growth), with GAAP diluted EPS turning to $3.11 from a $(0.18) loss last year and adjusted diluted EPS rising 25% YoY to $0.40; nine-month sales totaled $2,127.5 million (8.1% YoY) with adjusted diluted EPS at $1.16.
  • **Guidance Upgrade:** The company raised full-year 2026 guidance, increasing core sales growth to 3.75%–4.25%, adjusted EBITDA growth to 12.5%–14%, and adjusted diluted EPS to $1.54–$1.58.
  • **Capital Allocation & Strategy:** Management repurchased 386,000 shares for approximately $10 million (leaving $273 million in capacity) while gaining market share and expanding margins through the Envista Business System; a $428 million non-cash foreign currency gain was recognized due to legal entity dissolution.
Company
ENVISTA HOLDINGS CORP
Sector
Healthcare
Industry
Medical Instruments & Supplies